ArticleFrontiers in oncology2026

Preliminary exploration of the optimal timing of chemoimmunotherapy combined with radiotherapy for oligometastatic esophageal squamous cell carcinoma and analysis of prognostic factors: a multicenter retrospective study.

Tian Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.